Amgen "sector outperform," target price reduced

11.05.07 - CIBC World Markets

NEW YORK, May 11 (newratings.com) - Analysts at CIBC World Markets reiterate their "sector outperform" rating on Amgen Inc (AMGN). The target price has been reduced from $72 to $65.